DAWN
Day One Biopharmaceuticals, Inc. - Common Stock (DAWN)
$64
About Day One Biopharmaceuticals, Inc. - Common Stock (DAWN)
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.
Details
Daily high
$6.80
Daily low
$6.53
Price at open
$6.80
52 Week High
$16.76
52 Week Low
$6.08
Market cap
676.1M
Dividend yield
0.00%
Volume
862,232
Avg. volume
1.2M
P/E ratio
-9.97
Day One Biopharmaceuticals, Inc. - Common Stock News
Details
Daily high
$6.80
Daily low
$6.53
Price at open
$6.80
52 Week High
$16.76
52 Week Low
$6.08
Market cap
676.1M
Dividend yield
0.00%
Volume
862,232
Avg. volume
1.2M
P/E ratio
-9.97